CFTR and cystic fibrosis: With longitudinal gastrointestinal data rare in the specialised setting of ivacaftor treatment, and absent beyond the four week time point, we performed an uncontrolled, observational study of twelve patients with CF with one copy of the G551D CFTR mutation.